Physician
Premier Pain Management PLLC
Premier Pain Management PLLC was paid $1.85M by Medicaid between Sep 2019 and Dec 2024, across 36 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 40% of everything it billed.
33Billing provider infoPREMIER PAIN MANAGEMENT PLLC
FITCHBURG, MA 01420
FITCHBURG, MA 01420
33aNPI1386102614assigned 03/05/2019
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$1.85M
24GClaims59,691
24DCodes billed36
24AFirst – last monthSep 2019 – Dec 2024
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in Massachusetts
Rank by total paid#2 of 38
Median peer was paid$9K
This provider vs. median216×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 262 | $12K | |
| 2020 | 4,407 | $155K | |
| 2021 | 11,920 | $486K | |
| 2022 | 15,643 | $544K | |
| 2023 | 11,821 | $279K | |
| 2024incomplete | 15,638 | $373K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 40% | 14,505 | 12,395 | $746K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 6,450 | 5,194 | $247K |
| 64635 | 6.7% | 721 | 703 | $123K | |
| 64493 | 5.6% | 1,445 | 1,352 | $104K | |
| 62323 | 4.9% | 855 | 843 | $91K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.1% | 865 | 860 | $76K |
| 64636 | 3.7% | 722 | 703 | $69K | |
| 77002 | 2.8% | 3,641 | 2,439 | $52K | |
| 64494 | 2.8% | 1,445 | 1,352 | $52K | |
| 20610 | 2.4% | 3,362 | 2,204 | $44K | |
| 80305 | 2.2% | 7,864 | 6,690 | $40K | |
| 64483 | 1.3% | 255 | 245 | $24K |
24 more codes
| 64490 | 1.2% | 256 | $23K | |
| 64495 | 1.2% | 558 | $23K | |
| 99203 | Doctor's office visit, new patient (routine) | 1.1% | 375 | $21K |
| 76942 | <1% | 1,076 | $18K | |
| 20553 | <1% | 592 | $17K | |
| 62321 | <1% | 153 | $17K | |
| 64491 | <1% | 256 | $11K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 546 | $8K |
| L0648 | Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | <1% | 43 | $7K |
| 64484 | <1% | 177 | $7K | |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | <1% | 265 | $4K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,108 | $4K |
| J7332 | Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg | <1% | 39 | $4K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 4,245 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 411 | $3K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,020 | $2K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 352 | $2K |
| 64492 | <1% | 25 | $2K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 5,044 | $866.33 |
| 20611 | <1% | 14 | $701.16 | |
| 20552 | <1% | 31 | $608.05 | |
| 99443 | <1% | 31 | $522.10 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 346 | $499.50 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 598 | $109.95 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialQURESHI, OMAR (PROVIDER)